Adenovirus-mediated gene transfer in the treatment of pancreatic cancer

Pancreas

Volumn 26, Issue 3, 2003, Pages 274-278

  Pan, Xue ^a   Li, Zhao Shen ^a   Xu, Guo Ming ^a   Cui, Long ^a   Tu, Zhen Xing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus vector; Cytosine deaminase; Gene therapy; Pancreatic cancer

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFICACY; GENE REPLACEMENT THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; MOLECULAR CLONING; PANCREAS CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR LOCALIZATION;

ADENOVIRIDAE; ANIMALS; BYSTANDER EFFECT; CARCINOMA; CELL LINE, TUMOR; CYTOSINE DEAMINASE; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; PANCREATIC NEOPLASMS; TRANSDUCTION, GENETIC;

EID: 0037382452     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200304000-00011     Document Type: Article

References (18)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-41.
2. Humphreys MJ, Greenhalf W, Neoptolemos JP, et al. The potential for gene therapy in pancreatic cancer. Int J Pancreatol 1999;26:5-21.
3. Austin EA, Huber BH. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol 1993;43:380-7.
4. Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci USA 1992;89:33-7.
5. Cui L, Lin YZ, Jin GX, et al. Cytotoxic effect of the cytosine deaminase gene delivered by the adenovirus vector in murine gastric cancer. Chin J Dig 2001; 2:1-4.
6. Elsasser HP, Lehr U, Agricola B, et al. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1992; 61:295-306.
7. Kyriazis AP, McCombs WB 3rd, Sandberg AA, et al. Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse. Cancer Res 1983;43:4393-401.
8. Graham FL, Prevec L. Methods for construction of adenovirus vectors. Mol Biotechnol 1995;3:207-11.
9. He TC, Zhou S, DaCosta LT, et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA 1998;95:2509-14.
10. Evoy D, Hirschowitz EA, Naama HA, et al. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Surg Res 1997;69:226-31.
11. Block A, Chen SH, Kosai KI, et al. Adenoviral-mediated herpes simplex virus thymidine kinase gene transfer: regression of hepatic metastasis of pancreatic tumors. Pancreas 1997;15:25-34.
12. Huber BE, Austin EA, Richards CA, et al. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effect when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1994;91:8302-6.
13. Colombo BM, Bendettis S, Ottolenghi S, et al. The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice. Hum Gene Ther 1995;6:763-72.
14. DiMaio JM, Clary BM, Via DF, et al. Directed enzyme prodrug gene therapy for pancreatic cancer in vivo. Surgery 1994;116:205-13.
15. Ramesh R, Marrogi AJ, Munshi A, et al. In vivo analysis of the "bystander effect": a cytokine cascade. Exp Hematol 1996;24:829-38.
16. Pierrefite Carle V, Baque P, Carelli A, et al. Regression of experimental liver tumor after distant intra-hepatic injection of cylosine deaminase-expressing tumor cells and 5-fluorocytosine treatment. Int J Mol Med 2000;5:275-8.
17. Gagsndeep S, Brew R, Green B, et al. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect." Cancer Gene Ther 1996;3:83-8.
18. Bischoff JR, Kirn DH, Williams A, et al. An adenovirus mutant that replicates selectively in p53 deficient human tumor cells. Science 1996;274:373.